Skip to the main content

Meeting abstract

https://doi.org/10.15836/ccar2024.550

Pulmonary embolism in neuroleptic malignant syndrome

Ana Petretić orcid id orcid.org/0000-0002-5767-1206 ; University Hospital Rijeka, Rijeka, Croatia
Marija Tomac Stojmenović orcid id orcid.org/0000-0003-4257-0178 ; Insula County Hospital, Rab, Croatia


Full text: english pdf 142 Kb

page 550-550

downloads: 99

cite

Download JATS file


Abstract

Keywords

neuroleptic malignant syndrome; pulmonary embolism; antipsychotics

Hrčak ID:

328444

URI

https://hrcak.srce.hr/328444

Publication date:

13.12.2024.

Visits: 296 *



Introduction: Malignant neuroleptic syndrome (MNS) is life-threatening condition caused by psychotropic medications (1,2). Pulmonary embolism is known complication of antipsychotics, but incidence of pulmonary embolism in MNS is not known. Raised levels of creatine kinase can be helpful in diagnose but are not specific for MNS and there are cases with normal levels. (3)

Case report: We present the case of a 59-year-old female with severe bipolar disorder who presented with high fever, altered mental status and acute respiratory insufficiency. Upon presentation she was hospitalized in local institution for worsening of mental status receiving typical and atypical neuroleptics. On fourteenth day of hospitalization on psychiatric ward she was transferred to our Clinic because of acute respiratory insufficiency. High fever and altered mental status preceded, together with tachycardia and tachypnea but without hemodynamic instability. In laboratory tests special attention was on creatine kinase level which was not elevated. Before transport analgosedation and orotracheal intubation was preformed and she was mechanically ventilated. Upon admission CT pulmonary angiography showed bilateral pulmonary thromboembolism. Patient developed hemodynamic instability requiring vasopressors so systemic fibrinolytic therapy was applied. Hospitalization was complicated with severe thrombocytopenia, acute kidney failure, prolonged and difficult weaning from ventilator (with need of tracheostomy), partial epileptic seizures, bacteriemia (Staphylococcus species), and tetraparesis following prolonged immobility. Slowly, on tailored medical therapy together with intensive physiotherapy patient started to recover physically but then her mental status started to deteriorate again.

Conclusion: According to patient history, drug therapy, clinical presentation and excluded other possible causes we conclude that patient had MNS. Prompt reaction and therapy is necessary to reduce mortality in such lethal condition.

LITERATURE

1 

Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011 January;1(1):41–7. https://doi.org/10.1177/1941875210386491 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/23983836

2 

Duma SR, Fung VS. Drug-induced movement disorders. Aust Prescr. 2019 April;42(2):56–61. https://doi.org/10.18773/austprescr.2019.014 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/31048939

3 

Maniam T, Rahman MA. All elevated creatine kinase is not neuroleptic malignant syndrome. Med J Malaysia. 1994 September;49(3):252–4. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/7845275


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.